LEXX - Lexaria submits IND to begin Phase 1b study of DehyraTECH-CBD
2024-01-30 10:46:15 ET
More on Lexaria Bioscience Corp.
- Lexaria stock rallies 20% on positive GLP-1 drug delivery study
- Seeking Alpha’s Quant Rating on Lexaria Bioscience Corp.
- Historical earnings data for Lexaria Bioscience Corp.
- Financial information for Lexaria Bioscience Corp.